Listen: Pharma’s future in China, CRISPR meets Netflix, & where VC dollars come from
Should drug companies be free-speech advocates? Is your retirement dependent on CRISPR? And how useful is a glow-in-the-dark dog?
We discuss all that and more on the latest episode of “The Readout LOUD,” STAT’s biotech podcast. First we discuss how the fallout between the NBA and China raises questions for the drug industry and its international interests. Then, we speak to the co-directors of “Unnatural Selection,” a Netflix documentary series that dissects the stories, science, and ethics behind genome editing. Later, STAT’s Kate Sheridan joins us to explain the surprising roots of the billions of dollars that go into biotech startups. Finally, we embark upon a lightning round, touching on biohacker justice, drug shortages, and the fate of Hooters.
